Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

To date no prosthetic vascular prosthesis performs as well as autologous conduits for small diameter arterial reconstruction. We report the outcome of our first case using a new vascular prosthesis marketed by Cryolife, the SynerGraft. This Xenograft prostheses is claimed to eliminate the problems of the previous generation of gluteraldehyde treated grafts. Two 50 cm SynnerGrafts were anastomosed end to end and used as a femoral-posterior tibial bypass graft in a 68-year-old man who presented with an acutely ischaemic left leg. Our patient represented at 8 weeks with aneurysmal degeneration along the course of the graft. We urge caution in the use of these grafts until convincing data in humans is presented.

Original publication




Journal article


Eur J Vasc Endovasc Surg

Publication Date





42 - 44


Aged, Blood Vessel Prosthesis, Humans, Ischemia, Leg, Male